Plasma Feed Market Size was valued at USD 2.226 Billion in 2023. The plasma feed market industry is projected to grow from USD 2.35956 Billion in 2024 to USD 3.5479058 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.23 % during the forecast period (2024 - 2032). The increasing demand for high-quality animal protein, developing trends in animal health and nutrition, the expanding demand for high-quality animal protein, and the growing understanding of the advantages of plasma-based animal feeds in improving animal performance and general health, are the key market drivers enhancing market growth.
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
Market CAGR is driven by the growing requirement for high-quality animal nutrition. Animal performance in general, mortality, and gut health have all been proven to benefit from plasma. It enhances the feed's palatability, encourages intestine maturation, nourishes the mucosa's defenses against bacterial and viral infections, and fortifies the intestinal barrier. The market share of plasma meal will grow as it is increasingly used in veal replacements to provide comprehensive main feed for colostrum and prawns, poultry and fish with health-promoting characteristics. In the upcoming years, plasma. The increased use of plasma feed in pet food is a result of its carrageenan-based texture-modified components.
The market for plasma feed is still expanding due to several factors, including the rising demand for animal-based protein, the increased attention being given to animal health and welfare, and the growing acceptance of plasma feed as a highly digestible and nutrient-rich protein source for growing animals. Additionally, the expanding use of cutting-edge veterinary practices like precision nutrition and genetics is fueling the need for specialized agricultural products like plasma feed. It is growing as a result of increased funding for R&D initiatives to improve the effectiveness and caliber of plasma feed products. Additionally, it is anticipated that in the upcoming years, the market for plasma feed will gain more prospective customers as a result of the development of cutting-edge technologies and inventive processing methods as well as a focus on environmentally friendly and sustainable practices.
The market for plasma feed is being driven by the rising need for substitute protein sources in the animal feed sector as well as the rising need for plasma feed to replace antibiotics. Additionally, the rising demand for animal protein sources and limited land and water resources for the manufacturing of animal feed are driving the worldwide plasma protein market. Additionally, the projection year is anticipated to present a sizable potential due to the rising need for animal-based protein sources and the rising popularity of bovine plasma powder. Thus, driving the plasma feed market revenue.
Based on the source, the plasma feed market segmentation includes bovine, porcine, and others. The porcine category led the market in 2022 and is likely to maintain its dominance during the forecast period. Porcine plasma (SDPP) is a feed ingredient that contains highly digestible proteins and amino acids as well as considerable amounts of functional bioactive components such as immunoglobulins, transferrin, growth factors, peptides, and other biologically active components. Porcine blood meal provides several health advantages to animals and is widely used in poultry and porcine feed.
However, the rise of the bovine segment in the plasma feed market is driven by several interconnected factors that highlight the significance of plasma feed in enhancing the overall health, productivity, and sustainability of cattle farming. Plasma feed offers a highly digestible and balanced source of proteins, amino acids, vitamins, and minerals that are essential for the growth and well-being of cattle. This nutritional richness has been proven to enhance cattle performance, promote efficient weight gain, and contribute to improved overall health.
Based on application, the plasma feed market segment includes pet food, aquafeed, swine feed, and others. The pet food category holds a significant share of the market in 2022 and is predicted to maintain its dominance during the forecast period. The inclination of people to humanize pets and treat them like family members has resulted in a strong demand for better quality pet food, which has resulted in the increasing acceptance of plasma feed in pet food.
The growing tendency among pet owners to humanize their pets and consider them integral members of their families has reshaped the pet food industry. Pets are no longer just animals kept for utility; they are companions with emotional connections. This shift has led to a heightened awareness of pets' health and well-being, driving the demand for premium and nutritionally superior pet food options.
Figure 1: Plasma Feed Market, by Application, 2022 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
By region, the study provides market insights into North America, Europe, Asia-Pacific, and Rest of the World. North America dominates the market during the forecast period, due to the growing knowledge of the multiple benefits of plasma among North Americans, as well as a rise in the prevalence of respiratory illnesses. Further, the U.S. plasma feed market held the largest market share, and the Canadian plasma feed market was the fastest-growing market in the North American region.
Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 2: PLASMA FEED MARKET SHARE BY REGION 2022 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
Europe's plasma feed market accounts for the second-largest market share due to the expanding firms in the area embracing innovative technologies to quickly train deep learning models, Europe is predicted to grow at an accelerated rate in the plasma feed market during the forecast period.
The Asia-Pacific Plasma Feed Market is expected to grow at the fastest CAGR from 2023 to 2032. The Asia Pacific plasma feed market is expected to be the most valuable and to grow at the fastest rate over the same period. The continually growing economy has propelled the worldwide meat food industry in the region, which has in turn propelled the plasma feed business. According to the Food and Agriculture Organization (FAO), demand for animal products has increased in this region in recent years. Meat consumption, for example, has increased at a 5% annual pace, while dairy products have increased at a 3.5-4% annual rate. The region's increased demand for pigs, as well as China's increased beef consumption, are predicted to boost the number of slaughters, eventually enhancing the market supply requirement for plasma feed makers. NNP-T trains Al systems, while the Nervana NNP-1 handles inference. Moreover, China’s plasma feed market held the largest market share, and the Indian plasma feed market was the fastest-growing market in the Asia-Pacific region.
Leading market players are investing heavily in research and development to expand their product lines, which will help the plasma feed market grow even more. Market participants are also engaging in various strategic measures to grow their businesses, and footprint, with important market developments including contractual agreements, new product launches, mergers and acquisitions, higher investments, and collaboration with other organizations. The plasma feed industry must offer cost-effective items to expand and survive in a more competitive and rising market climate.
Manufacturing locally to minimize operational costs is one of the key business tactics manufacturers use in the plasma feed industry to benefit clients and increase the market sector. In recent years, the plasma feed industry has offered some of the most significant medical advantages. Major players in the plasma feed market, including Sera Sc India, Saria Group, Rocky Mountain Biologicals, LicanFood, Veos Group, Baxter International Inc., Grifolis S.A., CSL Limited, The Lauridsen Group Inc., PureteinAgri LLC., Darling Ingredients Inc., EcooFeed LLC., Accuray Inc., Boston Scientific Corp., and others, are attempting to increase market demand by investing in research and development operations.
Baxter International Inc. is a healthcare company that focuses on providing medical products and therapies in various fields, including renal care, medication delivery, pharmaceuticals, and more. One of the areas where Baxter has been involved is plasma therapies. Plasma therapies involve using plasma-derived products to treat various medical conditions. For instance, in 2022 ChemoSera S.A. was purchased by Baxter International Inc. The purchase will broaden Baxter's plasma fractionation product line and allow the business to grow its footprint in European markets.
Grifols S.A. is a Spanish multinational pharmaceutical and chemical company that specializes in the production of plasma-derived medicines, diagnostic systems, and hospital pharmacy products. The company has a significant presence in the field of plasma therapies. Grifols operates plasma collection centers where individuals can donate plasma. For instance, In 2022, Grifols S.A. purchased Hologic Inc. Grifols will be able to extend its supply of plasma fractionation products and services, as well as its footprint in the plasma fractionation industry, as a result of the acquisition of Hologic's business.
Plasma Feed Industry Developments
October 2022: Grifols opened a new albumin purification and filling operation in Dublin, Ireland, at its worldwide production and supply base.
September 2022: The Ministry of Health, Labour, and Welfare of Japan granted CSL Behring K.K. manufacturing and marketing approval for Berinert S.C. Injection 2000, a lyophilized human C1-esterase inhibitor concentrate for subcutaneous (SC) injection in plasma derivative, for the prevention of acute hereditary angioedema (HAE) attack.
April 2022: Shire Plc was bought by Takeda Pharmaceutical Company Limited in 2022. Takeda's product range will be expanded as a result of this purchase, allowing the business to increase its foothold in the plasma market for fractionation.
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)